CardioVascular BioTherapeutics (fka CVBT)

[walhall]

Question 11: Which of these statements was NOT made by one of the members of Venturis Therapeutics’s leadership team at one of the annual shareholders meetings?

A) Robert Schleizer: "We will receive a qualified audit as a going concern." (2018)

B) Calvin Wallen III: "Everyone wants to know as much as they can [about Venturis]. We would like to tell everyone as much as we can. But the more we speak to, the more we expose ourselves to other entities pirating our science and our work. There are certain things we are just not allowed to talk about. Therefore we have to hold those things close to ourselves." (2019)

C) Calvin Wallen III: "We anticipate re-opening the clinical trials relatively soon." (2016)

D) Calvin Wallen III: “[One of our achievements is] integrating ourselves in the Dallas biotech community.” (2016)

E) Dr. Laurence Meyerson: “Severe CAD [clinical trial], in Phase IIa, resumes in the first half of 2019.” (2018)

F) Grant Gordon: “It’s incredible what Calvin has done here by drifting the listless ship, iceberg [mumbles], swimming [pause]…FDA better. Thank you.” (2020)

(The correct answer is listed below)

This is part of our new Venturis Therapeutics educational trivia series. Unlike our cheap imitators who lack a single original thought in their minimally-educated brains, ours is an educational and fun exercise for the whole family while we're mostly not social distancing anymore (and are now sorry we didn't).

For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156608105

The correct answer is: (F). This was easy, for two reasons. One, because Venturis Therapeutics did not hold a shareholders meeting in 2020--in violation of its bylaws and stated promises to shareholders. Two, because since Calvin Wallen's hostile takeover, Grant Gordon has never spoken at a shareholders meeting (Mr. Wallen probably doesn't dare risk it). If you chose any answer other than (F), you haven't been paying attention.

For fun, let's go through and review each of these choices.

(A) Yes, Robert Schleizer stated it himself that Venturis received a qualified audit as a going concern. And nothing has changed materially for the better since then.

(B) Calvin Wallen himself has stated at multiple shareholders meetings that CVBT/Venturis was not going to be forthcoming with information about the company, in order to protect itself against hostile parties. And it hasn't been. Yet such "information" allegedly leaks out in "rumors" that are publicly shared (although good news rumors inevitably turn out to be false). Think about that. And review Question 10 in our quiz series if you're unclear what this might mean.

(C) Calvin Wallen has told us on more than one occasion (as have others) that the clinical trials would be resuming "soon." Not one clinical trial has been run since 2007. Mr. Wallen, would you care to define the word "soon" for us?

(D) I love this quote! Calvin Wallen told us what a great achievement it had been for Venturis to have successfully integrated itself into the Dallas biotech community. (There is one?) No further comment is necessary.

(E) Dr. Meyerson gave us a very specific date for the resumption of the Phase IIa trial. Maybe I missed it, but did that trial resume in 2019 as Dr. Meyerson indicated? What about in 2020?

Maybe this is a good time to review what a high-placed Venturis Therapeutics insider who left the company had to say:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891

For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156885999

And here are the earlier questions in our series:

Question 1: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716885

Question 2: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155768166

Question 3: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155830431

Question 4: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155887684

Question 5: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156041065

Question 6: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156227658

Question 7: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156355920

Question 8: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156535390

Question 9: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156702737

Question 10: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156857356